Endocrine FGFs and fetuin-A are dysregulated in metabolic disorders including obesity, type 2 diabetes, non-alcoholic fatty liver disease and polycystic ovary syndrome (PCOS). This evidence concerns the gene AHSG and metabolic dysfunction-associated steatotic liver disease.